Bruzek, Laura M. External Entity

Publications

Sort by

Selected publications

  • A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia.  Blood2007 Academic Article GET IT

Other